The Calmer Co International Limited (ASX:CCO)

Market Cap	5.34M -40.9%
Revenue (ttm)	8.12M +1.0%
Net Income	-3.81M
EPS	-0.00
Shares Out	5.34B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	161,100
Open	0.0010
Previous Close	0.0010
Day's Range	0.0010 - 0.0010
52-Week Range	0.0010 - 0.0050
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 26, 2026

About ASX:CCO

The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, New Zealand, the United States, and internationally. It operates through four segments: Fiji Kava Trading, SPE Fiji, Fiji Kava USA, and Danodan. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; flavoured and non-flavoured kava shots, tinctures, and traditional and instant drinking kava under the Taki Mai brand name; hemp, CBD oils, topical salves, and pet CBD oils under Danodan brand name. In addition,...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2014
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CCO

Financial Performance

In fiscal year 2026, ASX:CCO's revenue was 8.12 million, an increase of 1.01% compared to the previous year's 8.03 million. Losses were -3.81 million, -4.62% less than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 15, 2026

Data Sources Report a data error